JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiu, R. C.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiu, R. C.-J.
Related Collections
Right arrow Molecular biology
Right arrowRelated Article

J Thorac Cardiovasc Surg 2001;122:851-852
© 2001 The American Association for Thoracic Surgery


Editorials

Therapeutic cardiac angiogenesis and myogenesis: The promises and challenges on a new frontier

Ray C.-J. Chiu, MD, PhD

From McGill University, Montreal, Quebec, Canada.

Received for publication June 8, 2001. Accepted for publication June 27, 2001. Address for reprints: Ray Chu-Jeng Chiu, MD, PhD, Department of Surgery, Montreal General Hospital, McGill University, 1650 Cedar Ave, C9-169, Montreal, PQ H3G 1A4, Canada.


See related article on page 963.

Myocardial circulatory insufficiency, cardiomyocyte necrosis, and apoptosis play important roles in many pathologic conditions of the heart. Therapeutic approaches aimed at promoting angiogenesis and growing new heart muscle fibers, currently undergoing intensive investigation and early clinical trials, therefore hold considerable promise for the future. Genes encoding angiogenic factors and angiogenic growth factor proteins, such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor, are being delivered to the target tissue to induce growth of new blood vessels. For myogenesis, various progenitor and stem cells are being assessed as donor cells for implantation into the ventricular wall of injured hearts. Phase I and II clinical trials have already been undertaken for myocardial angiogenesis. Clinical studies into myogenesis have been recently initiated with implantation of autologous skeletal myoblasts into myocardial scar tissue. Although the results of phase I safety studies so far are promising, the establishment of efficacy requires rigorous phase II and III studies yet to come.

Cardiac myogenesis and angiogenesis represents a paradigm shift in our therapeutic approach, from substitution to regeneration . . . [Full Text of this Article]


Related Article

Angiogenesis by endothelial cell transplantation
Eung-Joong Kim, Ren-Ke Li, Richard D. Weisel, Donald A.G. Mickle, Zhi-Qiang Jia, Shinji Tomita, Tetsuro Sakai, and Terrence M. Yau
J. Thorac. Cardiovasc. Surg. 2001 122: 963-971. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
RadiologyHome page
A. Jacquier, C. B. Higgins, A. J. Martin, L. Do, D. Saloner, and M. Saeed
Injection of Adeno-associated Viral Vector Encoding Vascular Endothelial Growth Factor Gene in Infarcted Swine Myocardium: MR Measurements of Left Ventricular Function and Strain
Radiology, October 1, 2007; 245(1): 196 - 205.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. J. MacDonald, J. Luo, T. Saito, M. Duong, P.-L. Bernier, R. C.J. Chiu, and D. Shum-Tim
Persistence of marrow stromal cells implanted into acutely infarcted myocardium: Observations in a xenotransplant model
J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1114 - 1121.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
J. C Chachques, C. Salanson-Lajos, P. Lajos, A. Shafy, A. Alshamry, and A. Carpentier
Cellular Cardiomyoplasty for Myocardial Regeneration
Asian Cardiovasc Thorac Ann, September 1, 2005; 13(3): 287 - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. C. Chachques, F. Duarte, B. Cattadori, A. Shafy, N. Lila, G. Chatellier, J.-N. Fabiani, and A. F. Carpentier
Angiogenic growth factors and/or cellular therapy for myocardial regeneration: A comparative study
J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 245 - 253.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. C. Chachques, C. Acar, J. Herreros, J. C. Trainini, F. Prosper, N. D'Attellis, J.-N. Fabiani, and A. F. Carpentier
Cellular cardiomyoplasty: clinical application
Ann. Thorac. Surg., March 1, 2004; 77(3): 1121 - 1130.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. C.-J. Chiu
Reply to the Editor
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2117 - 2117.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Bittira, J.-Q. Kuang, A. Al-Khaldi, D. Shum-Tim, and R. C.-J. Chiu
In vitro preprogramming of marrow stromal cells for myocardial regeneration
Ann. Thorac. Surg., October 1, 2002; 74(4): 1154 - 1160.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The American Association for Thoracic Surgery.